Keybank National Association OH Invests $226,000 in Pediatrix Medical Group, Inc. $MD

Keybank National Association OH bought a new stake in Pediatrix Medical Group, Inc. (NYSE:MD) during the second quarter, HoldingsChannel reports. The fund bought 15,766 shares of the company’s stock, valued at approximately $226,000.

A number of other large investors have also added to or reduced their stakes in MD. GAMMA Investing LLC lifted its stake in Pediatrix Medical Group by 219.5% during the first quarter. GAMMA Investing LLC now owns 2,569 shares of the company’s stock worth $37,000 after purchasing an additional 1,765 shares during the last quarter. Marshall & Sullivan Inc. WA purchased a new position in shares of Pediatrix Medical Group during the 2nd quarter valued at about $41,000. AlphaQuest LLC lifted its position in Pediatrix Medical Group by 16.0% in the 1st quarter. AlphaQuest LLC now owns 5,877 shares of the company’s stock worth $85,000 after buying an additional 811 shares during the last quarter. Freedom Investment Management Inc. bought a new stake in Pediatrix Medical Group in the 2nd quarter worth approximately $151,000. Finally, Empirical Financial Services LLC d.b.a. Empirical Wealth Management purchased a new stake in Pediatrix Medical Group in the first quarter worth approximately $159,000. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have commented on MD shares. Zacks Research downgraded shares of Pediatrix Medical Group from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, October 7th. Wall Street Zen upgraded shares of Pediatrix Medical Group from a “buy” rating to a “strong-buy” rating in a research report on Saturday, October 4th. Leerink Partners boosted their price target on shares of Pediatrix Medical Group from $14.50 to $17.00 and gave the stock a “market perform” rating in a research note on Friday, September 5th. Truist Financial set a $17.00 price target on shares of Pediatrix Medical Group in a research report on Tuesday, October 14th. Finally, UBS Group lifted their price objective on Pediatrix Medical Group from $16.50 to $23.00 and gave the stock a “neutral” rating in a report on Wednesday. One analyst has rated the stock with a Buy rating and six have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $18.40.

Pediatrix Medical Group Trading Up 0.5%

NYSE:MD opened at $21.80 on Friday. The firm has a market capitalization of $1.90 billion, a P/E ratio of 16.90 and a beta of 1.20. The company has a quick ratio of 1.80, a current ratio of 1.80 and a debt-to-equity ratio of 0.70. The company has a fifty day moving average of $17.19 and a 200 day moving average of $15.05. Pediatrix Medical Group, Inc. has a 52 week low of $11.84 and a 52 week high of $22.38.

Pediatrix Medical Group (NYSE:MD) last announced its quarterly earnings results on Monday, November 3rd. The company reported $0.67 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.46 by $0.21. The business had revenue of $492.88 million for the quarter, compared to analyst estimates of $476.45 million. Pediatrix Medical Group had a net margin of 5.66% and a return on equity of 18.94%. The company’s revenue was down 3.6% on a year-over-year basis. During the same quarter last year, the firm earned $0.44 EPS. On average, research analysts predict that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.